Depressive spectrum disorders in cancer: prevalence, risk factors and screening for depression: a critical review

References

• World Health Organization (WHO): Global burden of mental disorders and the need for a comprehensive, coordinated response from health and social sectors at the country level. EB130/9, WHO, Geneva, 2011.
   Google Scholar
• Lépine JP, Briley M. The increasing burden of depression. Neuropsychiatr Dis Treat. 2011;7:3–7.
   PubMedGoogle Scholar
• Moussavi S, Chatterji S, Verdes E, et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007 Sep 8;370:851–858.
   PubMed Web of Science ®Google Scholar
• Pasquini M, Biondi M. Depression in cancer patients: a critical review. Clin Pract Epidemiol Ment Health. 2007;3:2.
   PubMedGoogle Scholar
• Smith H. Depression in cancer patients: Pathogenesis, implications and treatment. Oncology Letters. 2015;9:1509–1514.
   PubMed Web of Science ®Google Scholar
• Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer. 2009;115:5349–5361.
   PubMed Web of Science ®Google Scholar
• Dauchy S, Dolbeault S, Reich M. Depression in cancer patients. EJC Suppl. 2013;11:205–215.
   PubMedGoogle Scholar
• Passik SD, Dugan W, McDonald MV, et al. Oncologists' recognition of depression in their patients with cancer. J Clin Oncol. 1998;16:1594–1600.
   PubMed Web of Science ®Google Scholar
• Kissane DW. Unrecognised and untreated depression in cancer care. Lancet Psychiatry. 2014;1:32.
   Web of Science ®Google Scholar
• Block SD. Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians - American Society of Internal Medicine. Ann Intern Med. 2000;132:209–218.
   PubMed Web of Science ®Google Scholar
• Howell D, Keshavarz H, Esplen MJ, et al. on behalf of the Cancer Journey Advisory Group of the Canadian Partnership Against Cancer. A Pan Canadian Practice Guideline: Screening, Assessment and Care of Psychosocial Distress (Depression, Anxiety) in Adults with Cancer, Toronto: Canadian Partnership Against Cancer (Cancer Journey Advisory Group) and the Canadian Association of Psychosocial Oncology, July 2015.
   Google Scholar
• Rayner L, Price A, Hotopf M, et al. The development of evidence-based European guidelines on the management of depression in palliative cancer care. Eur J Cancer. 2011;47:702–712.
   PubMed Web of Science ®Google Scholar
• Rubin G, Berendsen A, Crawford SM, et al. The expanding role of primary care in cancer control. Lancet Oncol. 2015;16:1231–1272.
   PubMed Web of Science ®Google Scholar
• Butow P, Price MA, Shaw JM, et al. Clinical pathway for the screening, assessment and management of anxiety and depression in adult cancer patients: Australian guidelines. Psychooncology. 2015;24:987–1001.
   PubMed Web of Science ®Google Scholar
• Andersen BL, DeRubeis RJ, Berman BS, et al. American Society of Clinical Oncology.: Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014 May 20;32:1605–1619.
   PubMed Web of Science ®Google Scholar
• Krebber AM, Buffart LM, Kleijn G, et al. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology. 2014;23:121–130.
   PubMed Web of Science ®Google Scholar
• Walker J, Holm Hansen C, Martin P, et al. Prevalence of depression in adults with cancer: a systematic review. Ann Oncol. 2013;24:895–900.
   PubMed Web of Science ®Google Scholar
• Ng CG, Boks MP, Zainal NZ, et al. The prevalence and pharmacotherapy of depression in cancer patients. J Affect Disord. 2011;131:1–7.
   PubMed Web of Science ®Google Scholar
• Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;32:57–71.
   PubMedGoogle Scholar
• Pirl WF. Evidence report on the occurrence, assessment, and treatment of depression in cancer patients. J Natl Cancer Inst Monogr. 2004;32:32–39.
   PubMedGoogle Scholar
• National Institute for Health and Care Excellence (NICE): Depression in adults with a chronic physical health problem: recognition and management (CG91), NICE 2009. Clinical guideline Published: 28 October 2009 nice.org.uk/guidance/cg91.
   Google Scholar
• Rasic DT, Belik SL, Bolton JM, et al. Cancer, mental disorders, suicidal ideation and attempts in a large community sample. Psycho-Oncology. 2008;17:660–667.
   PubMed Web of Science ®Google Scholar
• Dalton SO, Laursen TM, Ross L, et al. Risk for hospitalization with depression after a cancer diagnosis: a nationwide, population-based study of cancer patients in Denmark from 1973 to 2003. J Clin Oncol. 2009;27:1440–1445.
   PubMed Web of Science ®Google Scholar
• Yang Y-L, Liu L, Wang Y, et al. The prevalence of depression and anxiety among Chinese adults with cancer: a systematic review and meta-analysis. BMC Cancer. 2013;13:393.
   PubMed Web of Science ®Google Scholar
• Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12:160–174.
   PubMed Web of Science ®Google Scholar
• Tecuta L, Tomba E, Grandi S, et al. Demoralization: a systematic review on its clinical characterization. Psychol Med. 2015;45:673–691.
   PubMed Web of Science ®Google Scholar
• Robinson S, Kissane DW, Brooker J, et al. A systematic review of the demoralization syndrome in individuals with progressive disease and cancer: a decade of research. J Pain Symptom Manage. 2015;49:595–610.
   PubMed Web of Science ®Google Scholar
• Tang PL, Wang HH, Chou FH. A systematic review and meta-analysis of demoralization and depression in patients with cancer. Psychosomatics. 2015;56:634–643.
   PubMed Web of Science ®Google Scholar
• Grassi L, Biancosino B, Marmai L, et al. Psychological factors affecting oncology conditions. Adv Psychosom Med. 2007;28:57–71.
   PubMed Web of Science ®Google Scholar
• Grassi L, Nanni MG. Demoralization syndrome: New insights in psychosocial cancer care. Cancer. 2016;122:2130–2133.
   PubMed Web of Science ®Google Scholar
• Watts S, Leydon G, Birch B, et al. Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open. 2014;4:e003901.
   PubMed Web of Science ®Google Scholar
• Jesse R, Fann JR, Anne M, et al. Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry. 2008;30:112–126.
   PubMed Web of Science ®Google Scholar
• Walker J, Hansen CH, Martin P, et al. Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data. Lancet Psychiatry. 2014;1:343–350.
   PubMed Web of Science ®Google Scholar
• Caplette-Gingras A, Savard J. Depression in women with metastatic breast cancer: a review of the literature. Palliat Support Care. 2008;6:377–387.
   PubMedGoogle Scholar
• Mass SW, Roorda C, Berendsen AJ, et al. The prevalence of long-term symptoms of depression and anxiety after breast cancer treatment: a systematic review. Maturitas. 2015;82:100–108.
   PubMed Web of Science ®Google Scholar
• Reich M, Lesur A, Perdrizet-Chevallier C. Depression, quality of life and breast cancer: a review of the literature. Breast Cancer Res Treat. 2008;110:9–17.
   PubMed Web of Science ®Google Scholar
• Lydiatt WM, Moran J, Burke WJ. A review of depression in the head and neck cancer patient. Clin Adv Hematol Oncol. 2009;7:397–403.
   PubMedGoogle Scholar
• Barber B, Dergousoff J, Slater L, et al. Depression and Survival in Patients With Head and Neck Cancer: A Systematic Review. JAMA Otolaryngol Head Neck Surg. 2016;142:284–288.
   PubMed Web of Science ®Google Scholar
• Boyd AD, Riba M. Depression and pancreatic cancer. J Natl Compr Canc Netw. 2007;5:113–116.
   PubMedGoogle Scholar
• Jansen L, Koch L, Brenner H, et al. Quality of life among long-term (≥5 years) colorectal cancer survivors-systematic review. Eur J Cancer. 2010;46:2879–2888.
   PubMed Web of Science ®Google Scholar
• Hotopf M, Chidgey J, Addington-Hall J, et al. Depression in advanced disease: a systematic review Part 1. Prevalence and case finding. Palliat Med. 2002;16:81–97.
   PubMed Web of Science ®Google Scholar
• Janberidze E, Hjermstad MJ, Haugen DF, EURO IMPACT, et al. How are patient populations characterized in studies investigating depression in advanced cancer? Results from a systematic literature review. J Pain Symptom Manage. 2014;48:678–698.
   PubMed Web of Science ®Google Scholar
• Zainal NZ, Nik-Jaafar NR, Baharudin A, et al. Prevalence of depression in breast cancer survivors: a systematic review of observational studies. Asian Pacific J Cancer Prev. 2013;4:2649–2656.
   Google Scholar
• Mitchell AJ, Ferguson DW, Gill J, et al. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol. 2013;14:721–732.
   PubMed Web of Science ®Google Scholar
• Prendes-Alvarez S, Nemeroff CB. Personalized Medicine: Prediction of Disease Vulnerability in Mood Disorders. Neurosci Lett. 2016;13. DOI: 10.1016/j.neulet.2016.09.049.
   PubMed Web of Science ®Google Scholar
• Young JJ, Bruno D, Pomara N. A review of the relationship between proinflammatory cytokines and major depressive disorder. J Affect Disord. 2014;169:15–20.
   PubMed Web of Science ®Google Scholar
• Postal M, Appenzeller S. The importance of cytokines and autoantibodies in depression. Autoimmunity Reviews. 2015;14:30–35.
   PubMed Web of Science ®Google Scholar
• Young JJ, Bruno D, Pomara N. A review of the relationship between proinflammatory cytokines and major depressive disorder. Journal of Affective Disorders. 2014;169:15–20.
   PubMed Web of Science ®Google Scholar
• Kupferberg A, Bicks L, Hasler G. Social functioning in major depressive disorder. Neurosci Biobehav Rev. 2016;69:313–332.
   PubMed Web of Science ®Google Scholar
• Belzung C, Willner P, Philippot P. Depression: from psychopathology to pathophysiology. Curr Opin Neurobiol. 2015;30:24–30.
   PubMed Web of Science ®Google Scholar
• Gold PW. The organization of the stress system and its dysregulation in depressive illness. Mol Psychiatry. 2015;20:32.
   PubMed Web of Science ®Google Scholar
• Benatti C, Blom JM, Rigillo G, et al. Disease-Induced Neuroinflammation and Depression. CNS Neurol Disord Drug Targets. 2016;15:414–433.
   PubMed Web of Science ®Google Scholar
• Reich M. Depression and cancer: recent data on clinical issues, research challenges and treatment approaches. Curr Opin Oncol. 2008;20:353–359.
   PubMed Web of Science ®Google Scholar
• Spiegel Giesel-Davis Depression and Cancer: Mechanisms and Disease Progression. Biol Psychiatry. 2003;54:269–282.
   PubMed Web of Science ®Google Scholar
• Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004;5:617–625.
   PubMed Web of Science ®Google Scholar
• Aldea M, Craciun L, Tomuleasa C, et al. Glucocorticoids and inflammation: a double-headed sword in depression? How do neuroendocrine and inflammatory pathways interact during stress to contribute to the pathogenesis of depression? j BUON. 2014;19:5–14.
   PubMed Web of Science ®Google Scholar
• Myers JS. Proinflammatory cytokines and sickness behavior: implications for depression and cancer-related symptoms. Oncol Nurs Forum. 2008;35:802–807.
   PubMed Web of Science ®Google Scholar
• Celano CM, Freudenreich O, Fernandez-Robles C, et al. Depressogenic effects of medications: a review. Dialogues Clin Neurosci. 2011;13:109–125.
   PubMedGoogle Scholar
• Pereira Dias G, Hollywood R, Bevilaqua MC, et al. Consequences of cancer treatments on adult hippocampal neurogenesis: implications for cognitive function and depressive symptoms. Neuro-oncology. 2014;16:476–492.
   PubMed Web of Science ®Google Scholar
• Gressier F, Calati R, Serretti A. 5-HTTLPR and gender differences in affective disorders: A systematic review. J Affect Disord. 2016;190:193–207.
   PubMed Web of Science ®Google Scholar
• Gilbert J, Haman KL, Dietrich MS, et al. Depression in patients with head and neck cancer and a functional genetic polymorphism of the serotonin transporter gene. Head Neck. 2012;34:359–364.
   PubMed Web of Science ®Google Scholar
• Grassi L, Rossi E, Cobianchi M, et al. Depression and serotonin transporter (5-HTTLPR) polymorphism in breast cancer patients. J Affect Disord. 2010;124:346–350.
   PubMed Web of Science ®Google Scholar
• Kim KR, Chung HC, Lee E, et al. Body image, sexual function and depression in Korean patients with breast cancer: modification by 5-HTT polymorphism. Support Care Cancer. 2012;20:2177–2182.
   PubMed Web of Science ®Google Scholar
• Suppli NP, Bukh JD, Moffitt TE, et al. 5-HTTLPR and use of antidepressants after colorectal cancer including a meta-analysis of 5-HTTLPR and depression after cancer. Transl Psychiatry. 2015;5:e631.
   PubMed Web of Science ®Google Scholar
• Brandão T, Schulz MS, Matos PM. Psychological adjustment after breast cancer: A systematic review of longitudinal studies. Psychooncology. 2016;20: doi: 10.1002/pon.4230.
   Web of Science ®Google Scholar
• De Vries AM, Forni V, Voellinger R, et al. Alexithymia in cancer patients: review of the literature. Psychother Psychosom. 2012;81:79–86.
   PubMed Web of Science ®Google Scholar
• Mols F, Thong MS, van de Poll-Franse LV, et al. Type D (distressed) personality is associated with poor quality of life and mental health among 3080 cancer survivors. J Affect Disord. 2012;136:26–34.
   PubMed Web of Science ®Google Scholar
• Husson O, Vissers PA, Denollet J, et al. The role of personality in the course of health-related quality of life and disease-specific health status among colorectal cancer survivors: A prospective population-based study from the PROFILES registry. Acta Oncol. 2015;54:669–677.
   PubMed Web of Science ®Google Scholar
• Zhang JK, Fang LL, Zhang DW, et al. Type D Personality in Gastric Cancer Survivors: Association With Poor Quality of Life, Overall Survival, and Mental Health. J Pain Symptom Manage. 2016;52:81–91.
   PubMed Web of Science ®Google Scholar
• Grassi L, Caruso R, Sabato S, The UniFe Psychiatry Working Group Coauthors, et al. Psychosocial screening and assessment in oncology and palliative care settings. Front Psychol. 2015;5:1485.
   PubMed Web of Science ®Google Scholar
• Mitchell AJ. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol. 2007;25:4670–4681.
   PubMed Web of Science ®Google Scholar
• Mitchell AJ, Meader N, Davies E, et al. Meta-analysis of screening and case finding tools for depression in cancer: evidence based recommendations for clinical practice on behalf of the Depression in Cancer Care consensus group. J Affect Disord. 2012;140:149–160.
   PubMed Web of Science ®Google Scholar
• Mitchell AJ. Are one or two simple questions sufficient to detect depression in cancer and palliative care? A Bayesian meta-analysis. Br J Cancer. 2008;98:1934–1943.
   PubMed Web of Science ®Google Scholar
• Donovan KA, Grassi L, McGinty HL, et al. Validation of the distress thermometer worldwide: state of the science. Psychooncology. 2014;23:241–250.
   PubMed Web of Science ®Google Scholar
• Wakefield CE, Butow PN, Aaronson NA, International Psycho-Oncology Society Research Committee, et al. Patient-reported depression measures in cancer: a meta-review. Lancet Psychiatry. 2015;2:635–647.
   PubMed Web of Science ®Google Scholar
• Aktas A, Walsh D, Kirkova J. The psychometric properties of cancer multisymptom assessment instruments: a clinical review. Support Care Cancer. 2015;23:2189–2202.
   PubMed Web of Science ®Google Scholar
• Wasteson E, Brenne E, Higginson IJ, European Palliative Care Research Collaborative (EPCRC), et al. Depression assessment and classification in palliative cancer patients: a systematic literature review. Palliat Med. 2009;23:739–753.
   PubMed Web of Science ®Google Scholar
• Mitchell AJ, Lord K, Symonds P. Which symptoms are indicative of DSMIV depression in cancer settings? An analysis of the diagnostic significance of somatic and non-somatic symptoms. J Affect Disord. 2012;138:137–148.
   PubMed Web of Science ®Google Scholar
• Fava GA, Freyberger HJ, Bech P, et al. Diagnostic criteria for use in psychosomatic research. Psychother Psychosom. 1995;63:1–8.
   PubMed Web of Science ®Google Scholar
• Cockram CA, Doros G, de Figueiredo JM. Diagnosis and measurement of subjective incompetence: the clinical hallmark of demoralization. Psychother Psychosom. 2009;78:342–345.
   PubMed Web of Science ®Google Scholar
• Kissane DW, Wein S, Love A, et al. The Demoralization Scale: a report of its development and preliminary validation. J Palliat Care. 2004;20:269–276.
   PubMed Web of Science ®Google Scholar
• Robinson S, Kissane DW, Brooker J, et al. Refinement and revalidation of the demoralization scale: The DS-II-internal validity. Cancer. 2016;122:2251–2259.
   PubMed Web of Science ®Google Scholar
• Robinson S, Kissane DW, Brooker J, et al. Refinement and revalidation of the demoralization scale: The DS-II-external validity. Cancer. 2016;122:2260–2267.
   PubMed Web of Science ®Google Scholar
• Rayner L, Loge JH, Wasteson E, EPCRC, European Palliative Care Research Collaborative, et al. The detection of depression in palliative care. Curr Opin Support Palliat Care. 2009;3:55–60.
   PubMedGoogle Scholar
• Bidstrup PE, Johansen C, Mitchell AJ. Screening for cancer-related distress: Summary of evidence from tools to programmes. Acta Oncologica. 2011;50:194–204.
   PubMed Web of Science ®Google Scholar
• Mitchell AJ, Vahabzadeh A, Magruder K. Screening for distress and depression in cancer settings: 10 lessons from 40 years of primary-care research. Psychooncology. 2011;20:572–584.
   PubMed Web of Science ®Google Scholar
• Meader N, Mitchell AJ, Chew-Graham C, et al. Case identification of depression in patients with chronic physical health problems: a diagnostic accuracy meta-analysis of 113 studies. Br J Gen Pract. 2011;61:e808–e820.
   PubMed Web of Science ®Google Scholar
• Strong V, Waters R, Hibberd C, et al. Management of depression for people with cancer (SMaRT oncology 1): a randomised trial. Lancet. 2008;372:40–48.
   PubMed Web of Science ®Google Scholar
• Walker J, Sharpe M. Depression care for people with cancer: a collaborative care intervention. Gen Hosp Psychiatry. 2009;31:436–441.
   PubMed Web of Science ®Google Scholar
• Sharpe M, Walker J, Holm Hansen C, SMaRT (Symptom Management Research Trials), et al. Oncology-2 Team. Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial. Lancet. 2014 Sep 20;384:1099–1108.
   PubMed Web of Science ®Google Scholar
• Duarte A, Walker J, Walker S, et al. Cost-effectiveness of integrated collaborative care for comorbid major depression in patients with cancer. J Psychosom Res. 2015;79:465–470.
   PubMed Web of Science ®Google Scholar
• Grassi L, Nanni MG, Caruso R. Emotional distress in cancer: screening policy, clinical limitations and educational needs. J Med Person. 2010;8:51–59.
   Google Scholar
• Grassi L, Caruso R, Hammelef K, et al. Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: a review. Int Rev Psychiatry. 2014;26:44–62.
   PubMed Web of Science ®Google Scholar
• Grassi L, Malacarne P, Maestri A, et al. Depression, psychosocial variables and occurrence of life events among patients with cancer. J Affect Disord. 1997;44:21–30.
   PubMed Web of Science ®Google Scholar
• Mitchell AJ, Meader N, Symonds P. Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: a meta-analysis. J Affect Disord. 2010;126:335–348.
   PubMed Web of Science ®Google Scholar
• Vodermaier A, Millman RD. Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: a systematic review and meta-analysis. Support Care Cancer. 2011;19:1899–1908.
   PubMed Web of Science ®Google Scholar
• Carey M, Noble N, Sanson-Fisher R, et al. Identifying psychological morbidity among people with cancer using the Hospital Anxiety and Depression Scale: time to revisit first principles?. Psychooncology. 2012;21:229–238.
   PubMed Web of Science ®Google Scholar
• Eaton WW, Smith C, Ybarra M, et al. : Center for Epidemiologic Studies Depression Scale: review and revision (CESD and CESD-R), in: M.E. Maruish (Ed.), The Use of Psychological Testing for Treatment Planning and Outcomes Assessment, Instruments for Adults (3rd ed.), 3, Lawrence Erlbaum, Mahwah, NJ, 2004, pp. 363–377.
   Google Scholar
• Baker F, Denniston M, Zabora J, et al. A POMS short form for cancer patients: psychometric and structural evaluation. Psychooncology. 2002;11:273–281.
   PubMed Web of Science ®Google Scholar
• Thekkumpurath P, Walker J, Butcher I, et al. Screening for major depression in cancer outpatients: the diagnostic accuracy of the 9-item patient health questionnaire. Cancer. 2011;117:218–227.
   PubMed Web of Science ®Google Scholar